Brachytherapy boost for prostate cancer: A national survey from Groupe curiethérapie - Société française de radiothérapie oncologique.
Fiche publication
Date publication
juillet 2019
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEIFFERT Didier
Tous les auteurs :
Lam Cham Kee D, Peiffert D, Hannoun-Lévi JM
Lien Pubmed
Résumé
Brachytherapy can be used for the treatment of every localized prostate cancer, notably as boost for intermediate- and high-risk prostate cancer. With the incidence of prostate cancer increasing significantly during the next decades and brachytherapy developing, we conducted a descriptive survey to analyse the current status of prostate brachytherapy in France to see if the future demands could be met.
Mots clés
Brachytherapy, Cancer de prostate, Curiethérapie, Enquête, Prostate cancer, Survey
Référence
Cancer Radiother. 2019 Jul 30;: